Eli Lilly and Company

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, H…

Drug Manufacturers - General

US, Indianapolis [HQ]

Board & Officers
Business Intelligence
Employee Voice
Mergers and Acquisitions
Qualified Risks
ESG Scores [Soon]

Strategy & Leadership

Officers & BofD Beta

All directors and officers of Eli Lilly and Company are sourced directly from the SEC or manually.
For the SEC we either use the Form 3/4/5 or, even better extract the compensation for each leader out of the audited proxy statement (DEF-14A).

Form 3/4/5
Proxy DEF-14A

Total Compensation

Shows the total compensation per mentioned executive and board director.
Each datapoint refers the most recent appearance of the corresponding person.

- No data, only available if we have DEF 14A compensations in place -

Officers

Name & Position	Research
Zakrowski Donald A SVP, Finance, & CAO	Transactions Compensations Speech	11/08/24 [Form 4]
Montarce Lucas EVP & CFO	Transactions Compensations Speech	11/05/24 [Form 4]
Hernandez Edgardo EVP & Pres., Mfg. Operations	Transactions Compensations Speech	11/05/24 [Form 4]
Dozier Eric EVP, HR & Diversity	Transactions Compensations Speech	11/05/24 [Form 4]
Van Naarden Jacob EVP & Pres., Lilly Oncology	Transactions Compensations Speech	11/01/24 [Form 4]
Skovronsky Daniel EVP, CSO & Pres. LRL & LLY Imm	Transactions Compensations Speech	09/12/24 [Form 4]
Ricks David A President, Chair, and CEO Also inside the BofD	Transactions Compensations Speech	08/21/24 [Form 4]
Hakim Anat EVP, GC & Secretary	Transactions Compensations Speech	08/13/24 [Form 4]
Seymour Melissa EVP, Global Quality	Transactions Compensations Speech	08/02/24 [Form 4]
Brooks Gordon J. Interim CFO, Group VP	Transactions Compensations Speech	07/19/24 [Form 3]
Rau Diogo EVP & CIDO	Transactions Compensations Speech	06/04/24 [Form 4]
Norton Johna EVP, Global Quality	Transactions Compensations Speech	06/03/24 [Form 4]
White Anne E. EVP & Pres, Lilly Neuroscience	Transactions Compensations Speech	02/14/24 [Form 4]
Ashkenazi Anat EVP & CFO	Transactions Compensations Speech	02/14/24 [Form 4]
Yuffa Ilya EVP & President, LLY Int'l	Transactions Compensations Speech	02/14/24 [Form 4]
Jonsson Patrik EVP&Pres, LLY Dia&Obe, LLY USA	Transactions Compensations Speech	02/14/24 [Form 4]
Weems Alonzo EVP, ERM & CECO	Transactions Compensations Speech	02/14/24 [Form 4]

Board of Directors (BofD)

Name & Position	Research
Sulzberger Gabrielle Director	Transactions Compensations Speech	12/17/24 [Form 4]
Johnson Kimberly H Director	Transactions Compensations Speech	12/17/24 [Form 4]
Hedley Mary Lynne Director	Transactions Compensations Speech	12/17/24 [Form 4]
Alvarez Ralph Director	Transactions Compensations Speech	12/17/24 [Form 4]
Moeller Jon R Director	Transactions Compensations Speech	12/04/24 [Form 3]
Walker Karen Director	Transactions Compensations Speech	11/20/24 [Form 4]
Kaelin William G Jr Director	Transactions Compensations Speech	11/20/24 [Form 4]
Jackson Jamere Director	Transactions Compensations Speech	11/20/24 [Form 4]
Baicker Katherine Director	Transactions Compensations Speech	11/20/24 [Form 4]